![]()
Due to the poor performance of our investments we decided effective June 30th, 2011 to liquidate our fund and return the remaining cash to our investors. 4/15/2011, Eos re-opened its Vancouver, British Columbia office. 1/01/2011, Eos refocused its resources on identifying and investing in U.S. and Canadian biotechnology and natural resource companies. 2/12/2010, Eos arranged and funded a $2,000,000 bridge loan to Sichuan based Southwest China Cement, to repay existing debt in advance of a $20 million high-yield debt plus warrants financing to fund the completion of its Ziping cement plant expansion at the heart of the 2008 earthquake devastated region. 12/24/2009, Eos arranged and funded a $1,000,000 bridge loan to MDRNA Inc., (NASDAQ: MRNA) secured by the intellectual property and equipment of the company. MDRNA is a biotechnology company focused on developing therapeutics based on RNA interference (RNAi) techonology. 10/26/2009, Eos made a private equity investment in Shandong Longkang Fruity Juice Co., the exclusive producer of super-premium pears and juice concentrate from the Five Dragon River in Laiyang City. 8/28/2009, Eos completed open market and block purchases of Emisphere Technologies Inc. (OTCBB: EMIS). Emisphere is in late phase III development of an oral version of salmon calcitonin for Novartis, a multi-billion dollar opportunity. 5/17/2009, Eos completed the second closing of its largest investment to date in Southwest China Cement (formerly Sichuan Zhiquan Cement Group), a cement manufacturer in Sichuan. The $40 million convertible preferred stock financing funded technological upgrade and expansion of Zhiquan's existing plants. 10/25/2008, Eos successfully advised and completed the simultaneous exercise of warrants, short-term debt and equity financing totaling $750,000 allowing China Wind Systems (Amex: CWS) to buy rolled ring manufacturing equipment. 9/26/2008, Eos closed its largest investment to date in Southwest China Cement (formerly Sichuan Zhiquan Cement Group), a cement manufacturer in Sichuan. The $40 million convertible preferred stock financing will fund technological upgrade and expansion of Zhiquan's existing plants. 5/22/2008, Eos's largest investor, One Horizon Foundation, provided emergency financial assistance to earthquake victims in Baihua village near the Zhiquan Ziping cement factory. 4/29/2008, Eos completed the block trade purchase of $2 million worth of West China Cement (WCC.L - London Stock Exchange) from a failed hedge fund. WCC's stock had lost half its value due to the hedge fund selling. After Eos bought the shares the stock rebounded and the company successfully completed a $60 million investment from Credit Suisse. 1/20/2008, Eos researched, advised and invested in the $10.0 million preferred stock investment in Sichuan based Tianyin Pharmaceuticals, a leading manufacturer and supplier engaged in the development, manufacturing, marketing and sale of traditional Chinese medicines and modern pharmaceuticals in China. For more information, please visit http://www.tianyinpharma.com/ 5/31/2007, Eos researched, advised and invested in the $3.4 million preferred stock investment in China Education Alliance, a leading educational service company offering high-quality online education materials and on-site training and tutoring in China. For more information, please visit http://www.chinaeducationalliance.com |